Winway Health Desk
Lonza JV to produce live biotherapeutic products for gut bacteria field
The FDA and the pharma industry have taken note as the nutrition industry has promoted gut bacteria for preventing disease. Now, Swiss CDMO Lonza is getting...
AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate
A partnership between a large British drugmaker and a startup that discovers drugs using artificial intelligence has borne fruit.
Oxford, UK-based Exscientia said Wednesday that...
FiercePharmaAsia—Daiichi’s new CEO and $6.9B AZ deal; Keytruda China market debate
Daiichi Sankyo's plan to refocus on oncology paid off as AstraZeneca agreed to shell out $1.35 billion upfront for its lead antibody drug conjugate. But...
An interesting telemedicine story from Brazil told in Israel
Editor’s note: This is the part of a series of articles emerging from an invitation by the Israeli Export Institute to Arundhati Parmar, editor-in-chief...
FDA declares 40 generics free of carcinogens as ‘sartan’ recalls continue
As recalls on blood pressure drugs continue to plague drugmakers, the FDA declared a slate of 40 generic pills safe to use.
On Thursday, the agency...
RepScrubs is trying to cut down on hospital acquired infection risk...
Hospital acquired infections are a huge multi-billion dollar problem for providers, with one of the largest risks being surgical site infections. In some cases...
After Apotex founder’s murder, family weighs sale worth up to $3B:...
The family in control of Canadian generics maker Apotex is weighing a sale, Bloomberg reports. (Pixabay)
It’s been a tumultuous year and a half...
In Transition: Almost Home Kids
Young hospital patients with medically complex issues, such as traumatic brain injury or severe Down syndrome, often can’t be discharged until their homes and...
Moderate muscle strength linked with lower type 2 diabetes risk
Maintaining moderate muscle strength could help adults lower their risk of type 2 diabetes, US researchers suggest.A team from the Iowa State...
Pfizer uses real-world data to score Ibrance breast cancer nod in...
Breast cancer is a rare disease in men, making it tough for drugmakers to conduct clinical trials. But Pfizer came up with a solution.
The...
